lnu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Legal Transplants in the field of pharmaceutical patents: A Way to Achieve International Harmonisation or the Source of Deeper Divergences
Linnaeus University, School of Business and Economics, Department of Management Accounting and Logistics. Stockholm University.ORCID iD: 0000-0003-1211-4972
2016 (English)In: IIC-International Review of Industrial Property and Copyright Law, ISSN 0018-9855, E-ISSN 2195-0237, Vol. 47, no 8, 891-911 p.Article in journal (Refereed) Published
Abstract [en]

Modern lawmaking in the field of pharmaceutical patents and surrounding regulation is to a considerable extent based on legal transplants. Legal transplantation contributes to international harmonisation without requiring an international convention, something very attractive for actors in the pharmaceutical sector operating on an international market. Despite its informal character, and alleged efficiency and simplicity in the transfer of legal rules from one jurisdiction to the other, it requires certain caution. A legal rule may very rarely be seen in complete isolation from the rest of the legal system, since in some cases it is not possible to foresee the results of the legal rule in the exporting country before the transplant takes place. In the field of pharmaceuticals, significant examples of legal transplants are the Bolar exemption and the Supplementary Protection Certificate, both transplanted to the EU by the same US Act, the Hatch-Waxman Act. This article evaluates these two legal rules, comparing their strengths and weaknesses to those of the original provisions in order to highlight different aspects of the process of legal transplantation and the effect they have on the formation of the transplanted rules.

Place, publisher, year, edition, pages
2016. Vol. 47, no 8, 891-911 p.
Keyword [en]
legal transplants, SPC, patents, pharmaceuticals
National Category
Law (excluding Law and Society)
Research subject
Law
Identifiers
URN: urn:nbn:se:lnu:diva-65000DOI: 10.1007/s40319-016-0526-1OAI: oai:DiVA.org:lnu-65000DiVA: diva2:1107003
Available from: 2017-06-08 Created: 2017-06-08 Last updated: 2017-11-08Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Papadopoulou, Frantzeska
By organisation
Department of Management Accounting and Logistics
In the same journal
IIC-International Review of Industrial Property and Copyright Law
Law (excluding Law and Society)

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 10 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf